Department of Pharmacology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Purinergic Signal. 2004 Dec;1(1):67-74. doi: 10.1007/s11302-004-5069-0.
The orphan receptor GPR80 (also called GPR99) was recently reported to be the P2Y(15) receptor activated by AMP and adenosine and coupled to increases in cyclic AMP accumulation and intracellular Ca(2+) mobilization (Inbe et al. J Biol Chem 2004; 279: 19790-9). However, the cell line (HEK293) used to carry out those studies endogenously expresses A(2A) and A(2B) adenosine receptors as well as multiple P2Y receptors, which complicates the analysis of a potential P2Y receptor. To determine unambiguously whether GPR80 is a P2Y receptor subtype, HA-tagged GPR80 was either stably expressed in CHO cells or transiently expressed in COS-7 and HEK293 cells, and cell surface expression was verified by radioimmunoassay (RIA). COS-7 cells overexpressing GPR80 showed a consistent twofold increase in basal inositol phosphate accumulation. However, neither adenosine nor AMP was capable of promoting accumulation of either cyclic AMP or inositol phosphates in any of the three GPR80-expressing cells. A recent paper (He et al. Nature 2004; 429: 188-93) reported that GPR80 is a Gq-coupled receptor activated by the citric acid cycle intermediate, alpha-ketoglutarate. Consistent with this report, alpha-ketoglutarate promoted inositol phosphate accumulation in CHO and HEK293 cells expressing GPR80, and pretreatment of GPR80-expressing COS-7 cells with glutamate dehydrogenase, which converts alpha-ketoglutarate to glutamate, decreased basal levels of inositol phosphates. Taken together, these data demonstrate that GPR80 is not activated by adenosine, AMP or other nucleotides, but instead is activated by alpha-ketoglutarate. Therefore, GPR80 is not a new member of the P2Y receptor family.
孤儿受体 GPR80(也称为 GPR99)最近被报道为 AMP 和腺苷激活的 P2Y(15)受体,并与环 AMP 积累和细胞内 Ca(2+)动员的增加偶联(Inbe 等人,J Biol Chem 2004;279:19790-9)。然而,用于开展这些研究的细胞系(HEK293)内源性表达 A(2A)和 A(2B)腺苷受体以及多种 P2Y 受体,这使得对潜在 P2Y 受体的分析变得复杂。为了明确确定 GPR80 是否是 P2Y 受体亚型,HA 标记的 GPR80 要么稳定表达在 CHO 细胞中,要么瞬时表达在 COS-7 和 HEK293 细胞中,并通过放射免疫测定(RIA)验证细胞表面表达。过表达 GPR80 的 COS-7 细胞显示基础肌醇磷酸盐积累一致增加两倍。然而,在这三种表达 GPR80 的细胞中,腺苷或 AMP 都不能促进环 AMP 或肌醇磷酸盐的积累。最近的一篇论文(He 等人,Nature 2004;429:188-93)报道 GPR80 是柠檬酸循环中间体 α-酮戊二酸激活的 Gq 偶联受体。与该报告一致,α-酮戊二酸促进 CHO 和 HEK293 细胞中表达 GPR80 的肌醇磷酸盐积累,并且用谷氨酸脱氢酶预处理表达 GPR80 的 COS-7 细胞,该酶将 α-酮戊二酸转化为谷氨酸,降低了基础肌醇磷酸盐水平。总之,这些数据表明 GPR80 不是由腺苷、AMP 或其他核苷酸激活,而是由 α-酮戊二酸激活。因此,GPR80 不是 P2Y 受体家族的新成员。